Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 76

1.

Polysubstance addiction vulnerability in mental illness: Concurrent alcohol and nicotine self-administration in the neurodevelopmental hippocampal lesion rat model of schizophrenia.

Sentir AM, Bell RL, Engleman EA, Chambers RA.

Addict Biol. 2020 Jan;25(1):e12704. doi: 10.1111/adb.12704. Epub 2018 Dec 28.

PMID:
30592364
2.

On Mourning and Recovery: Integrating Stages of Grief and Change Toward a Neuroscience-Based Model of Attachment Adaptation in Addiction Treatment.

Chambers RA, Wallingford SC.

Psychodyn Psychiatry. 2017 Winter;45(4):451-473. doi: 10.1521/pdps.2017.45.4.451.

3.

Assessment of risk behaviors in patients with opioid prescriptions: A study of indiana's inspect data.

Greene MS, Chambers RA, Yiannoutsos CT, Wright ER, Steele GK, Zollinger TW.

Am J Addict. 2017 Dec;26(8):822-829. doi: 10.1111/ajad.12639. Epub 2017 Nov 16.

PMID:
29143401
4.

Prescription drug monitoring program data tracking of opioid addiction treatment outcomes in integrated dual diagnosis care involving injectable naltrexone.

Sajid A, Whiteman A, Bell RL, Greene MS, Engleman EA, Chambers RA.

Am J Addict. 2016 Oct;25(7):557-64. doi: 10.1111/ajad.12441. Epub 2016 Sep 20.

5.

Toward early estimation and treatment of addiction vulnerability: radial arm maze and N-acetyl cysteine before cocaine sensitization or nicotine self-administration in neonatal ventral hippocampal lesion rats.

Rao KN, Sentir AM, Engleman EA, Bell RL, Hulvershorn LA, Breier A, Chambers RA.

Psychopharmacology (Berl). 2016 Dec;233(23-24):3933-3945. Epub 2016 Sep 17.

6.

The Impact of a Home-Based Diabetes Prevention and Management Program on High-Risk American Indian Youth.

Kenney A, Chambers RA, Rosenstock S, Neault N, Richards J, Reid R, Nelson L, Begay M, Grass R, Parker S, Barlow A.

Diabetes Educ. 2016 Oct;42(5):585-95. doi: 10.1177/0145721716658357. Epub 2016 Jul 14.

PMID:
27422151
7.

Pseudoaddiction: Fact or Fiction? An Investigation of the Medical Literature.

Greene MS, Chambers RA.

Curr Addict Rep. 2015;2(4):310-317. Epub 2015 Oct 1. Review.

8.

A Home-Visiting Diabetes Prevention and Management Program for American Indian Youth: The Together on Diabetes Trial.

Chambers RA, Rosenstock S, Neault N, Kenney A, Richards J, Begay K, Blackwater T, Laluk O, Duggan C, Reid R, Barlow A.

Diabetes Educ. 2015 Dec;41(6):729-47. doi: 10.1177/0145721715608953. Epub 2015 Oct 8.

PMID:
26450222
9.

Transcranial magnetic stimulation: potential treatment for co-occurring alcohol, traumatic brain injury and posttraumatic stress disorders.

Herrold AA, Kletzel SL, Harton BC, Chambers RA, Jordan N, Pape TL.

Neural Regen Res. 2014 Oct 1;9(19):1712-30. doi: 10.4103/1673-5374.143408. Review.

10.

Nicotine effects in adolescence and adulthood on cognition and α₄β₂-nicotinic receptors in the neonatal ventral hippocampal lesion rat model of schizophrenia.

Berg SA, Sentir AM, Bell RL, Engleman EA, Chambers RA.

Psychopharmacology (Berl). 2015 May;232(10):1681-92. doi: 10.1007/s00213-014-3800-2. Epub 2014 Nov 13.

11.

Prescription drug monitoring program inquiry in psychiatric assessment: detection of high rates of opioid prescribing to a dual diagnosis population.

Hackman DT, Greene MS, Fernandes TJ, Brown AM, Wright ER, Chambers RA.

J Clin Psychiatry. 2014 Jul;75(7):750-6. doi: 10.4088/JCP.14m09020.

12.

The iatrogenic epidemic of prescription drug abuse: county-level determinants of opioid availability and abuse.

Wright ER, Kooreman HE, Greene MS, Chambers RA, Banerjee A, Wilson J.

Drug Alcohol Depend. 2014 May 1;138:209-15. doi: 10.1016/j.drugalcdep.2014.03.002. Epub 2014 Mar 14.

PMID:
24679840
13.

Selective effects of D- and L-govadine in preclinical tests of positive, negative, and cognitive symptoms of schizophrenia.

Lapish CC, Ahn KC, Chambers RA, Ashby DM, Ahn S, Phillips AG.

Neuropsychopharmacology. 2014 Jun;39(7):1754-62. doi: 10.1038/npp.2014.23. Epub 2014 Jan 30.

14.

Alcohol use and craving among Veterans with mental health disorders and mild traumatic brain injury.

Herrold AA, Jordan N, High WM, Babcock-Parziale J, Chambers RA, Smith B, Evans CT, Li X, Mallinson T, Jenkins S, Pape TL.

J Rehabil Res Dev. 2014;51(9):1397-410. doi: 10.1682/JRRD.2013.07.0170.

15.
16.

Nicotine is more addictive, not more cognitively therapeutic in a neurodevelopmental model of schizophrenia produced by neonatal ventral hippocampal lesions.

Berg SA, Sentir AM, Cooley BS, Engleman EA, Chambers RA.

Addict Biol. 2014 Nov;19(6):1020-31. doi: 10.1111/adb.12082. Epub 2013 Aug 6.

17.

Cortical-striatal gene expression in neonatal hippocampal lesion (NVHL)-amplified cocaine sensitization.

Chambers RA, McClintick JN, Sentir AM, Berg SA, Runyan M, Choi KH, Edenberg HJ.

Genes Brain Behav. 2013 Jul;12(5):564-75. doi: 10.1111/gbb.12051. Epub 2013 Jun 22.

18.

Adult hippocampal neurogenesis in the pathogenesis of addiction and dual diagnosis disorders.

Chambers RA.

Drug Alcohol Depend. 2013 Jun 1;130(1-3):1-12. doi: 10.1016/j.drugalcdep.2012.12.005. Epub 2012 Dec 29. Review.

19.

A peptide derived from endostatin ameliorates organ fibrosis.

Yamaguchi Y, Takihara T, Chambers RA, Veraldi KL, Larregina AT, Feghali-Bostwick CA.

Sci Transl Med. 2012 May 30;4(136):136ra71. doi: 10.1126/scitranslmed.3003421.

20.

Auditory steady state responses in a schizophrenia rat model probed by excitatory/inhibitory receptor manipulation.

Vohs JL, Chambers RA, O'Donnell BF, Krishnan GP, Morzorati SL.

Int J Psychophysiol. 2012 Nov;86(2):136-42. doi: 10.1016/j.ijpsycho.2012.04.002. Epub 2012 Apr 12.

21.

Effects of alcohol availability, access to alcohol, and naltrexone on self-reported craving and patterns of drinking in response to an alcohol-cue availability procedure.

Kruse MI, Radnovich AJ, Kalapatapu RK, Mehdiyoun N, Chambers RA, Davidson D.

J Stud Alcohol Drugs. 2012 Mar;73(2):205-15.

22.

Nicotine exposure during adolescence enhances behavioral sensitivity to nicotine during adulthood in Wistar rats.

Bracken AL, Chambers RA, Berg SA, Rodd ZA, McBride WJ.

Pharmacol Biochem Behav. 2011 Jul;99(1):87-93. doi: 10.1016/j.pbb.2011.04.008. Epub 2011 Apr 17.

23.

Alcohol seeking and consumption in the NVHL neurodevelopmental rat model of schizophrenia.

Berg SA, Czachowski CL, Chambers RA.

Behav Brain Res. 2011 Apr 15;218(2):346-9. doi: 10.1016/j.bbr.2010.12.017. Epub 2010 Dec 22.

24.

Ventral and dorsal striatal dopamine efflux and behavior in rats with simple vs. co-morbid histories of cocaine sensitization and neonatal ventral hippocampal lesions.

Chambers RA, Sentir AM, Engleman EA.

Psychopharmacology (Berl). 2010 Sep;212(1):73-83. doi: 10.1007/s00213-010-1929-1. Epub 2010 Jul 15.

25.

Dazed and confused by self-medication.

Chambers RA.

Am J Psychiatry. 2010 May;167(5):600; author reply 600-1. doi: 10.1176/appi.ajp.2010.10010099. No abstract available.

26.

The Dual Diagnosis Physician-infrastructure Assessment Tool: examining physician attributes and dual diagnosis capacity.

Chambers RA, Connor MC, Boggs CJ, Parker GF.

Psychiatr Serv. 2010 Feb;61(2):184-8. doi: 10.1176/ps.2010.61.2.184.

27.

Cortical-striatal integration of cocaine history and prefrontal dysfunction in animal modeling of dual diagnosis.

Chambers RA, Sentir AM, Conroy SK, Truitt WA, Shekhar A.

Biol Psychiatry. 2010 Apr 15;67(8):788-92. doi: 10.1016/j.biopsych.2009.09.006. Epub 2009 Oct 31.

28.

Auditory sensory gating in the neonatal ventral hippocampal lesion model of schizophrenia.

Vohs JL, Chambers RA, Krishnan GP, O'Donnell BF, Hetrick WP, Kaiser ST, Berg S, Morzorati SL.

Neuropsychobiology. 2009;60(1):12-22. doi: 10.1159/000234813. Epub 2009 Aug 14.

29.

GABAergic modulation of the 40 Hz auditory steady-state response in a rat model of schizophrenia.

Vohs JL, Chambers RA, Krishnan GP, O'Donnell BF, Berg S, Morzorati SL.

Int J Neuropsychopharmacol. 2010 May;13(4):487-97. doi: 10.1017/S1461145709990307. Epub 2009 Jul 23.

31.

The neonatal ventral hippocampal lesion as a heuristic neurodevelopmental model of schizophrenia.

Tseng KY, Chambers RA, Lipska BK.

Behav Brain Res. 2009 Dec 7;204(2):295-305. doi: 10.1016/j.bbr.2008.11.039. Epub 2008 Dec 3. Review.

32.

Accentuated behavioral sensitization to nicotine in the neonatal ventral hippocampal lesion model of schizophrenia.

Berg SA, Chambers RA.

Neuropharmacology. 2008 Jun;54(8):1201-7. doi: 10.1016/j.neuropharm.2008.03.011. Epub 2008 Mar 28.

33.

Neonatal amygdala lesions: co-occurring impact on social/fear-related behavior and cocaine sensitization in adult rats.

Chambers RA, Sajdyk TJ, Conroy SK, Lafuze JE, Fitz SD, Shekhar A.

Behav Neurosci. 2007 Dec;121(6):1316-27.

34.

A scale-free systems theory of motivation and addiction.

Chambers RA, Bickel WK, Potenza MN.

Neurosci Biobehav Rev. 2007;31(7):1017-45. Epub 2007 May 3. Review.

35.

Animal Modeling and Neurocircuitry of Dual Diagnosis.

Chambers RA.

J Dual Diagn. 2007 Mar;3(2):19-29.

37.

Ethanol sensitization in a neurodevelopmental lesion model of schizophrenia in rats.

Conroy SK, Rodd Z, Chambers RA.

Pharmacol Biochem Behav. 2007 Feb;86(2):386-94. Epub 2006 Aug 28.

38.

Huntington disease as a dual diagnosis disorder: data from the National Research Roster for Huntington disease patients and families.

Ehret JC, Day PS, Wiegand R, Wojcieszek J, Chambers RA.

Drug Alcohol Depend. 2007 Jan 12;86(2-3):283-6. Epub 2006 Aug 22.

39.

Natural reward-related learning in rats with neonatal ventral hippocampal lesions and prior cocaine exposure.

Chambers RA, Jones RM, Brown S, Taylor JR.

Psychopharmacology (Berl). 2005 May;179(2):470-8. Epub 2004 Nov 25.

40.
41.

Regulation of affect by the lateral septum: implications for neuropsychiatry.

Sheehan TP, Chambers RA, Russell DS.

Brain Res Brain Res Rev. 2004 Aug;46(1):71-117. Review.

PMID:
15297155
42.

Locomotor sensitization to cocaine in rats with olfactory bulbectomy.

Chambers RA, Sheehan T, Taylor JR.

Synapse. 2004 Jun 1;52(3):167-75.

PMID:
15065217
43.

Simulated apoptosis/neurogenesis regulates learning and memory capabilities of adaptive neural networks.

Chambers RA, Potenza MN, Hoffman RE, Miranker W.

Neuropsychopharmacology. 2004 Apr;29(4):747-58.

44.

Dose-ranging kinetics and behavioral pharmacology of naltrexone and acamprosate, both alone and combined, in alcohol-dependent subjects.

Johnson BA, O'Malley SS, Ciraulo DA, Roache JD, Chambers RA, Sarid-Segal O, Couper D.

J Clin Psychopharmacol. 2003 Jun;23(3):281-93.

PMID:
12826990
45.

Developmental neurocircuitry of motivation in adolescence: a critical period of addiction vulnerability.

Chambers RA, Taylor JR, Potenza MN.

Am J Psychiatry. 2003 Jun;160(6):1041-52. Review.

46.

Neurodevelopment, impulsivity, and adolescent gambling.

Chambers RA, Potenza MN.

J Gambl Stud. 2003 Spring;19(1):53-84. Review.

PMID:
12635540
48.

A neurobiological basis for substance abuse comorbidity in schizophrenia.

Chambers RA, Krystal JH, Self DW.

Biol Psychiatry. 2001 Jul 15;50(2):71-83. Review.

49.

Schizophrenia and pathological gambling.

Potenza MN, Chambers RA.

Am J Psychiatry. 2001 Mar;158(3):497-8. No abstract available.

PMID:
11229999
50.

Glutamate and post-traumatic stress disorder: toward a psychobiology of dissociation.

Chambers RA, Bremner JD, Moghaddam B, Southwick SM, Charney DS, Krystal JH.

Semin Clin Neuropsychiatry. 1999 Oct;4(4):274-81. Review.

PMID:
10553033

Supplemental Content

Loading ...
Support Center